Geode Capital Management’s Reviva Pharmaceuticals RVPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $171K | Buy |
448,202
+29,063
| +7% | +$11.1K | ﹤0.01% | 3925 |
|
|
2025
Q1 | $400K | Buy |
419,139
+107,438
| +34% | +$102K | ﹤0.01% | 3625 |
|
|
2024
Q4 | $564K | Buy |
311,701
+33,205
| +12% | +$60.1K | ﹤0.01% | 3561 |
|
|
2024
Q3 | $401K | Buy |
278,496
+42,376
| +18% | +$61K | ﹤0.01% | 3680 |
|
|
2024
Q2 | $302K | Buy |
236,120
+16,003
| +7% | +$20.5K | ﹤0.01% | 3763 |
|
|
2024
Q1 | $832K | Buy |
220,117
+41,311
| +23% | +$156K | ﹤0.01% | 3432 |
|
|
2023
Q4 | $921K | Buy |
178,806
+7,614
| +4% | +$39.2K | ﹤0.01% | 3386 |
|
|
2023
Q3 | $836K | Buy |
171,192
+20,243
| +13% | +$98.8K | ﹤0.01% | 3400 |
|
|
2023
Q2 | $885K | Buy |
150,949
+5,519
| +4% | +$32.3K | ﹤0.01% | 3405 |
|
|
2023
Q1 | $609K | Hold |
145,430
| – | – | ﹤0.01% | 3575 |
|
|
2022
Q4 | $618K | Buy |
145,430
+67,355
| +86% | +$286K | ﹤0.01% | 3569 |
|
|
2022
Q3 | $124K | Sell |
78,075
-2,598
| -3% | -$4.13K | ﹤0.01% | 4465 |
|
|
2022
Q2 | $88K | Buy |
80,673
+2,598
| +3% | +$2.83K | ﹤0.01% | 4635 |
|
|
2022
Q1 | $192K | Buy |
78,075
+1,111
| +1% | +$2.73K | ﹤0.01% | 4407 |
|
|
2021
Q4 | $217K | Hold |
76,964
| – | – | ﹤0.01% | 4441 |
|
|
2021
Q3 | $313K | Buy |
76,964
+9,240
| +14% | +$37.6K | ﹤0.01% | 4252 |
|
|
2021
Q2 | $329K | Buy |
+67,724
| New | +$329K | ﹤0.01% | 4125 |
|